7GC is proud to welcome Michael Polansky as a Senior Advisor to the firm. Michael is based in San Francisco and will advise on matters related to growth investing as well as leveraging his network among some of the Valley's most highly respected entrepreneurs and venture capital firms.
Michael serves as the CEO of Parker Group, the San Francisco-based organization that manages the business, investment, political and charitable interests of Silicon Valley entrepreneur and philanthropist Sean Parker. Prior to his current role Michael was a Principal at Founders Fund working directly with Sean Parker and Peter Thiel and previously an Investor at Ray Dalio's Bridgewater Group. In addition to his considerable background as an investor Michael has worked as a entrepreneur, founder of political and policy groups and founder of philanthropy organizations in his work with the Parker Group.
Full biography below:
Michael Polansky is the CEO of the Parker Group, the San Francisco-based organization that manages the business, investment, political and charitable interests of Silicon Valley entrepreneur and philanthropist Sean Parker. As CEO, Michael’s role is to build the business, organizational or investment models to support Sean’s vision to find creative and novel solutions to challenges spanning a wide variety of areas across technology, life sciences, economic development, civic engagement and public policy.
Since 2008, Michael has worked closely with Parker to build a large portfolio of private technology companies across consumer internet, life sciences, and advanced technology.
In 2013, he co-founded the Economic Innovation Group (EIG), a bipartisan public policy organization that initially proposed and architected Opportunity Zones.
In 2015, he co-founded and helped launch the Parker Foundation, a $600 million private philanthropy vehicle dedicated to the aggressive pursuit of large-scale systemic change in Life Sciences, Global Public Health, and Civic Engagement. Most recently, he co-founded the Parker Institute for Cancer Immunotherapy, an unprecedented collaboration between the country’s leading immunologists and cancer centers: Memorial Sloan Kettering Cancer Center, Stanford University, University of California, Los Angeles, University of California, San Francisco, the University of Pennsylvania, and the University of Texas MD Anderson Cancer Center.
Michael serves on the board of several technology companies and major nonprofits including Economic Innovation Group, and the Parker Institute for Cancer Immunotherapy.
Prior to joining the Parker Group, Michael was a Senior Investment Associate at Bridgewater and a Principal at Founders Fund where he focused on consumer internet and emerging technology. He is a graduate from Harvard University with a degree in Applied Mathematics and Computer Science.